Document Detail


Pharmacoeconomic analysis of conservatively treated patients with nephropathies in western Slovakia regions.
MedLine Citation:
PMID:  12190047     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The prevalence of patients with chronic nephropathies leading to the end stage of renal failure (ESRF) is increased. The conservative therapy of patients in the phase of ESRF as well as the performance of hemodialysis represent an extensive burden on health care budgets. AIM: The aim of the study was to evaluate the financial expenses for medications in group of conservatively treated patients with nephropathies. PATIENTS AND METHOD: One hundred and two patients (56 females, 46 males) aged 21-84 years with nephropathies collected from three out-patient departments of nephrology in the regions of Bratislava and Nitra (Western Slovakia) were enrolled into the study. RESULTS: The total financial expenses represented 2,889,778 Sk The average expense per 1 patient/1 year was 28,331 Sk and that of 1 patient/1 day was 77.6 Sk, respectively. Antihypertensive therapy represented 1st position (29.4%) of the total financial cost followed by keto-analogs (27.5%), hypolipideamics (14.8%), drugs for disorders of calcium metabolism (14.4%) and antianaemics (6.2%), respectively. The group of "other" drugs represented 7.7% of total costs. CONCLUSIONS: Results show that the financial expenses for pharmacotherapy in conservatively treated patients with nephropathies are high, but significantly less expensive in comparison with hemodialysis (700,000-1,000,000 Sk/year/patient). The prevention and the slowing down of the progression of renal disease seem to be crucial in the management of nephropathies. The therapeutic approach in conservatively treated patients with renal diseases was rational and up to date. (Tab. 1 Fig. 5, Ref. 12. )
Authors:
K Gazdikova; V Springer; P Korecka; F Gazdik
Related Documents :
602777 - A quantitative study of glomeruli in idiopathic nephrosis with minimal or no glomerular...
15942677 - Direct effect of plasma permeability factors from patients with idiopatic fsgs on nephr...
12525387 - Diffuse endothelial dysfunction is common to anca associated systemic vasculitis and po...
8510707 - Prognosis of untreated patients with idiopathic membranous nephropathy.
12859087 - Cervical dentin hypersensitivity. part iii: resolution following occlusal equilibration.
9609407 - Hyperlactatemia during acute severe asthma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Bratislavské lekárske listy     Volume:  103     ISSN:  0006-9248     ISO Abbreviation:  Bratisl Lek Listy     Publication Date:  2002  
Date Detail:
Created Date:  2002-08-22     Completed Date:  2002-09-13     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0065324     Medline TA:  Bratisl Lek Listy     Country:  Slovakia    
Other Details:
Languages:  eng     Pagination:  131-4     Citation Subset:  IM    
Affiliation:
Institute of Preventive and Clinical Medicine, Bratislava, Slovakia. gazdikova@upkm.sk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Drug Costs*
Female
Health Care Costs
Humans
Kidney Diseases / drug therapy,  economics*
Male
Middle Aged
Slovakia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunosuppressive treatment of Crohn's disease with fistulae.
Next Document:  Changes of decartograms under gravitational acceleration and microgravity.